Paid Clinical Trials in Texas

Texas has 5,347 paid clinical trials enrolling now across cities including Houston, Dallas and San Antonio. Search by condition, age, or phase to find compensated research studies accepting participants near you.

Research sites in Texas include MD Anderson Cancer Center, Baylor College of Medicine and UT Southwestern, running studies across oncology, cardiology, neurology, and more. Both patients and healthy volunteers may qualify. Most studies offer compensation for time and travel.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: September 17, 2026.

Filter results

Filter results

State

City

Recruitment status

Phase

Study type

Intervention

Condition

Sex

Age

Healthy volunteers only

4,652 clinical trials

Get a weekly email when new trials open in Houston, TX.

Engineered HSV-1 M032 for the Treatment of Children and Adults With Newly Diagnosed Diffuse Midline Glioma After Standard of Care Radiation

for Glioma

1 location in Houston

Sponsor: M.D. Anderson Cancer Center

Sex: All·Age: 36 Months+

Code: NCT07076498·Phase 1·Recruiting·Listed Jul 2025

Apply to this trial

Treatment of Immune Checkpoint Inhibitor-related Diarrhea and/ or Colitis With Ustekinumab in Cancer Patients

for Cancer

Drug: Ustekinumab

1 location in Houston

Sponsor: M.D. Anderson Cancer Center

Sex: All·Age: 18+

Code: NCT06807593·Phase 2·Recruiting·Listed Feb 2025

Apply to this trial

A RCT of Spectacles With Aspherical Lenslets or 0.05% Atropine for Myopia Control

for Myopia

Sites in Houston +16 more locations

Sponsor: Jaeb Center for Health Research

Sex: All·Age: 5 - 11

Code: NCT07095894·Phase 3·Recruiting·Listed Jul 2025

Apply to this trial

Endometrial Cancer, Risk Factors and Prevention Strategies: Perspectives of Patients and At-Risk Women

for Endometrial Cancer

1 location in Houston

Sponsor: M.D. Anderson Cancer Center

Sex: Female·Age: 18+

Code: NCT06409052·Recruiting·Listed May 2024

Apply to this trial

Ponatinib Hydrochloride as Second Line Therapy in Treating Patients With Chronic Myeloid Leukemia in Chronic Phase Resistant or Intolerant to Imatinib Mesylate, Dasatinib, or Nilotinib

for Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive

1 location in Houston

Sponsor: M.D. Anderson Cancer Center

Sex: All·Age: 18+

Code: NCT01746836·Phase 2·Recruiting·Listed Dec 2012

Apply to this trial

Cardiovascular Injury and Cardiac Fitness in Locally Advanced Non-Small Cell Lung Cancer Patients Receiving Model Based Personalized Chemoradiation

for Locally Advanced Lung Non-Small Cell Carcinoma

1 location in Houston

Sponsor: M.D. Anderson Cancer Center

Sex: All·Age: 18+

Code: NCT05010109·Recruiting·Listed Aug 2021

Apply to this trial

Neoadjuvant Lenvatinib and Pembrolizumab for IVC Tumor Thrombus

for Renal Cell Carcinoma

1 location in Dallas

Sponsor: University of Texas Southwestern Medical Center

Sex: All·Age: 18+

Code: NCT05319015·Phase 2·Recruiting·Listed Apr 2022

Apply to this trial

TAS-102 With or Without Celecoxib in ctDNA-defined Minimal Residual Disease in Colorectal Cancer After Completion of Adjuvant Chemotherapy

for Colorectal Cancer

1 location in Houston

Sponsor: M.D. Anderson Cancer Center

Sex: All·Age: 18+

Code: NCT05343013·Phase 2·Recruiting·Listed Apr 2022

Apply to this trial

Replacing Invasive Cystoscopy With Urine Testing for Non-muscle Invasive Bladder Cancer Surveillance

for Non-muscle-invasive Bladder Cancer

Sites in Dallas +7 more locations

Sponsor: White River Junction Veterans Affairs Medical Center

Sex: All·Age: 18+

Code: NCT05796375·Phase 2·Recruiting·Listed Apr 2023

Apply to this trial

High Dose Ruxolitinib and Allogeneic Stem Cell Transplantation in Myelofibrosis Patients With Splenomegaly

for Splenomegaly

Drug: Ruxolitinib

1 location in Houston

Sponsor: M.D. Anderson Cancer Center

Sex: All·Age: 18 - 75

Code: NCT06345495·Phase 2·Recruiting·Listed Apr 2024

Apply to this trial

A Phase I/II Study of CAR.70-Engineered IL15-Transduced Cord Blood-Derived NK Cells With TGF-beta Receptor 2 (TGFBR2) Knock Out in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapsed/Refractory Myeloid Malignancies

for Myeloid Malignancies

1 location in Houston

Sponsor: M.D. Anderson Cancer Center

Sex: All·Age: 18 - 80

Code: NCT06930651·Phase 1, Phase 2·Recruiting·Listed Apr 2025

Apply to this trial

A Phase I Study of Hyper-CVAD In Combination With Venetoclax In Pediatric Patients With Relapsed or Refractory Acute Leukemias That Are of the Lymphoid Lineage Including Bi-Phenotypic or Undifferentiated Leukemias

for Refractory Acute Leukemia

Drug: Venetoclax

1 location in Houston

Sponsor: M.D. Anderson Cancer Center

Sex: All·Age: 2 - 21

Code: NCT06466395·Phase 1·Recruiting·Listed Jun 2024

Apply to this trial

Sentinel Node Biopsy in Endometrial Cancer

for Endometrial Cancer Stage I

1 location in Houston

Sponsor: Queensland Centre for Gynaecological Cancer

Sex: Female·Age: 18+

Code: NCT04073706·Phase 3·Recruiting·Listed Aug 2019

Apply to this trial

Quality of Life and Function of Patients With Pelvic Tumors After Undergoing Hemipelvectomy

for Malignant Primary Pelvic Neoplasm

1 location in Houston

Sponsor: M.D. Anderson Cancer Center

Sex: All·Age: All ages

Code: NCT05134142·Recruiting·Listed Nov 2021

Apply to this trial

Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma

for Medulloblastoma

Sites in Houston, Dallas +8 more locations

Sponsor: St. Jude Children's Research Hospital

Sex: All·Age: Up to 59 Months

Code: NCT05535166·Phase 2·Recruiting·Listed Sep 2022

Apply to this trial

Pilot Trial for WounDx™ Clinical Decision Support Tool

for Wounds

Sites in Fort Sam Houston +4 more locations

Sponsor: Henry M. Jackson Foundation for the Advancement of Military Medicine

Sex: All·Age: 18 - 65

Code: NCT06921707·Recruiting·Listed Apr 2025

Apply to this trial

Non-invasive Ventilation in Reducing the Need for Intubation in Patients With Cancer and Respiratory Failure

for Hematopoietic and Lymphoid Cell Neoplasm

1 location in Houston

Sponsor: M.D. Anderson Cancer Center

Sex: All·Age: 18+

Code: NCT02464696·Recruiting·Listed Jun 2015

Apply to this trial

Venetoclax With Combination Chemotherapy in Treating Patients With Newly Diagnosed or Relapsed or Refractory Acute Myeloid Leukemia

for High Risk Myelodysplastic Syndrome

Drug: Venetoclax

1 location in Houston

Sponsor: M.D. Anderson Cancer Center

Sex: All·Age: 18+

Code: NCT03214562·Phase 1, Phase 2·Recruiting·Listed Jul 2017

Apply to this trial

Indwelling Pleural Catheters With or Without Doxycycline in Treating Patients With Malignant Pleural Effusions

for Pleural Neoplasm

1 location in Houston

Sponsor: M.D. Anderson Cancer Center

Sex: All·Age: 18+

Code: NCT03465774·Recruiting·Listed Mar 2018

Apply to this trial

Ivosidenib and Venetoclax With or Without Azacitidine in Treating Patients With IDH1 Mutated Hematologic Malignancies

for Acute Myeloid Leukemia

Drug: Venetoclax

Sites in Houston +3 more locations

Sponsor: M.D. Anderson Cancer Center

Sex: All·Age: 18+

Code: NCT03471260·Phase 1, Phase 2·Recruiting·Listed Mar 2018

Apply to this trial

Enasidenib and Azacitidine in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia and IDH2 Gene Mutation

for Acute Bilineal Leukemia

1 location in Houston

Sponsor: M.D. Anderson Cancer Center

Sex: All·Age: 18+

Code: NCT03683433·Phase 2·Recruiting·Listed Sep 2018

Apply to this trial

Olaparib With Cediranib or AZD6738 for the Treatment of Advanced or Metastatic Germline BRCA Mutated Breast Cancer

for Advanced Breast Carcinoma

1 location in Houston

Sponsor: M.D. Anderson Cancer Center

Sex: Female·Age: 18+

Code: NCT04090567·Phase 2·Recruiting·Listed Sep 2019

Apply to this trial

Venetoclax, SL-401, and Chemotherapy for the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm

for Blastic Plasmacytoid Dendritic Cell Neoplasm

Drug: Venetoclax

1 location in Houston

Sponsor: M.D. Anderson Cancer Center

Sex: All·Age: 18+

Code: NCT04216524·Phase 2·Recruiting·Listed Jan 2020

Apply to this trial

MRE Scan for the Assessment of Differences in Tissue Stiffness Between Radiation Necrosis and Recurrent Glioma in Patients With Previously Treated Gliomas

for Glioma

1 location in Houston

Sponsor: M.D. Anderson Cancer Center

Sex: All·Age: 18+

Code: NCT04373720·Recruiting·Listed May 2020

Apply to this trial

Nivolumab, Fluorouracil, and Interferon Alpha 2B for the Treatment of Unresectable Fibrolamellar Cancer

for Stage III Hepatocellular Carcinoma AJCC v8

Drug: Nivolumab

1 location in Houston

Sponsor: M.D. Anderson Cancer Center

Sex: All·Age: 12+

Code: NCT04380545·Phase 1, Phase 2·Recruiting·Listed May 2020

Apply to this trial

Minimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer, LANCE Trial

for Advanced Ovarian Carcinoma

Sites in Houston +11 more locations

Sponsor: M.D. Anderson Cancer Center

Sex: Female·Age: 18+

Code: NCT04575935·Phase 3·Recruiting·Listed Oct 2020

Apply to this trial

The Rise in Robotic Atypical Segmentectomies

for Lung Carcinoma

1 location in Houston

Sponsor: M.D. Anderson Cancer Center

Sex: All·Age: All ages

Code: NCT04644952·Recruiting·Listed Nov 2020

Apply to this trial

Establishing a Tumor Registry for Patients With Neuroendocrine Carcinoma of the Cervix

for Cervical Large Cell Neuroendocrine Carcinoma

1 location in Houston

Sponsor: M.D. Anderson Cancer Center

Sex: All·Age: All ages

Code: NCT04723095·Recruiting·Listed Jan 2021

Apply to this trial

Evaluating the Impact of Limited Compared With Intense Post-Operative Surveillance on Patient-Reported Outcomes in Patients With Stage II-III Soft Tissue Sarcoma of the Trunk and Extremities

for Stage II Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8

1 location in Houston

Sponsor: M.D. Anderson Cancer Center

Sex: All·Age: 18+

Code: NCT04751409·Phase 2·Recruiting·Listed Feb 2021

Apply to this trial

Serial Advanced Magnetic Resonance Imaging Scan for Guidance of Personalized Adaptive Radiotherapy for High Grade Glioma

for Malignant Glioma

1 location in Houston

Sponsor: M.D. Anderson Cancer Center

Sex: All·Age: 18+

Code: NCT04771806·Recruiting·Listed Feb 2021

Apply to this trial

Impact of Project ECHO on Improving the Quality of Palliative Care in Patients With Advanced Cancer and Their Caregivers in Underserved Areas of Kenya, Nigeria, Ghana, South Africa, India, and Ethiopia

for Advanced Malignant Solid Neoplasm

1 location in Houston

Sponsor: M.D. Anderson Cancer Center

Sex: All·Age: All ages·Accepts healthy volunteers

Code: NCT04984551·Phase 2·Recruiting·Listed Jul 2021

Apply to this trial

Patient Perceptions Around Quality of Care Through Telemedicine in Neuro-Oncology

for Central Nervous System Neoplasm

1 location in Houston

Sponsor: M.D. Anderson Cancer Center

Sex: All·Age: 18+

Code: NCT04988009·Recruiting·Listed Aug 2021

Apply to this trial

Treatment of Cognitive Deficits in Multiple Sclerosis With High-Definition Transcranial Direct Current Stimulation

for Multiple Sclerosis, Relapsing-Remitting

1 location in Richardson

Sponsor: The University of Texas at Dallas

Sex: All·Age: 18 - 65

Code: NCT05958381·Recruiting·Listed Jul 2023

Apply to this trial

Endogenous Oxalate Synthesis in Idiopathic Calcium Oxalate Kidney Stone Disease

for Kidney Stones

Sites in Dallas +1 more location

Sponsor: University of Alabama at Birmingham

Sex: All·Age: 18 - 80·Accepts healthy volunteers

Code: NCT06989320·Recruiting·Listed May 2025

Apply to this trial

A Phase II Open-label Study of Olutasidenib Post-transplant Maintenance Therapy for Patients With IDH1-mutated Myeloid Malignancies

for Myeloid Malignancies

1 location in Houston

Sponsor: M.D. Anderson Cancer Center

Sex: All·Age: 18 - 75

Code: NCT06668584·Phase 2·Recruiting·Listed Oct 2024

Apply to this trial

A Phase Ib Study of Rezatapopt in Combination With Azacitidine in Patients With TP53Y220C Mutant Myeloid Malignancies (Acute Myeloid Leukemia or Myelodysplastic Syndrome)

for Myelodysplastic Syndrome

Drug: rezatapopt

Sites in Houston +1 more location

Sponsor: M.D. Anderson Cancer Center

Sex: All·Age: 18+

Code: NCT06616636·Phase 1·Recruiting·Listed Sep 2024

Apply to this trial

A Phase 2 Study Evaluating Olutasidenib in Patients With IDH1-mutated Clonal Cytopenia of Undetermined Significance and Lower-risk Myelodysplastic/Syndromes/Chronic Myelomonocytic Leukemia.

for Myelodysplastic Syndromes

Sites in Houston +1 more location

Sponsor: M.D. Anderson Cancer Center

Sex: All·Age: 18+·Accepts healthy volunteers

Code: NCT06566742·Phase 2·Recruiting·Listed Aug 2024

Apply to this trial

Systemic Therapy of Open-label Prophylactic Pravastatin or Pentoxifylline/Tocopherol Prevention of Lymphedema Advancing to Eventual Fibrosis: an Interventional Registry-embedded Bayesian Randomized Trial for Radiation Sequelae (STOP4-LATE-FIBROSE)

for Lymphedema

1 location in Houston

Sponsor: M.D. Anderson Cancer Center

Sex: All·Age: 18+

Code: NCT06494111·Phase 2·Recruiting·Listed Jul 2024

Apply to this trial

Phase 1b/2 Study of Decitabine and Venetoclax in Combination With the Targeted Mutant IDH1 Inhibitor Olutasidenib

for Mutant IDH1 Inhibitor Olutasidenib

Drug: Venetoclax

Sites in Houston +4 more locations

Sponsor: M.D. Anderson Cancer Center

Sex: All·Age: 18+

Code: NCT06445959·Phase 1, Phase 2·Recruiting·Listed Jun 2024

Apply to this trial

Humidity in Incubators for Tiny Infants

for Extremely Premature Infant

Sites in Houston, San Antonio +7 more locations

Sponsor: The University of Texas Health Science Center, Houston

Sex: All·Age: 0 Days - 1 Day

Code: NCT06399861·Recruiting·Listed May 2024

Apply to this trial